Position in VANI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,202
+$711 QoQ
Shares Held
3,389
-2.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 38 holders
Holding Since
Jun 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VANI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,940,254,192 across 425 Biotechnology names. VANI ranks #348 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in VANI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,202 | 3,389 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,491 | 3,491 | Shares | Defined | 2026-05-13 | |
| 2025-03-31 | $69 | 66 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $82 | 71 | Shares | Defined | 2025-02-12 | |
| 2023-12-31 | $105 | 103 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $51 | 50 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $22 | 19 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $19 | 19 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $16 | 19 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $43 | 19 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||